UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035173
Receipt number R000040084
Scientific Title Study on the change of coagulation in pediatric patients with steroid pulse therapy and systemic steroid administration
Date of disclosure of the study information 2018/12/10
Last modified on 2018/12/07 19:08:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the change of coagulation in pediatric patients with steroid pulse therapy and systemic steroid administration

Acronym

Study on the change of coagulation in pediatric patients with steroid pulse therapy and systemic steroid administration

Scientific Title

Study on the change of coagulation in pediatric patients with steroid pulse therapy and systemic steroid administration

Scientific Title:Acronym

Study on the change of coagulation in pediatric patients with steroid pulse therapy and systemic steroid administration

Region

Japan


Condition

Condition

Disease undergoing steroid pulse therapy, the steroid systemic administration

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will examine the change in coagulation at the time of administration of steroid by comparing the change of each coagulation factor before and after the steroid pulse therapy presumed high risk of thrombosis and systemic administration of steroid.

Basic objectives2

Others

Basic objectives -Others

If clothematological changes at the time of use of steroids in various disease states are clarified, it becomes possible to carry out prophylactic treatment of more appropriate thrombus in accordance with the disease state in future daily practice.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Before and after administration of steroid, PT, APTT, Fibrinogen, D-dimer, as well as coagulation related factors and fibrinolysis related factors are measured.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Pediatric patients with steroid pulse therapy or steroid systemic administration are included.

Key exclusion criteria

Abort when subjects and their families indicate intention to withdraw.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Chiai Nagae

Organization

St. Marianna University School of Medicine

Division name

Department of pediatrics

Zip code


Address

2-16-1, Sugao, Miyamae-ku, Kawasaki city, Kanagawa, Japan

TEL

044-977-8111

Email

chiai-oi@marianna-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yotaro Umezawa

Organization

St. Marianna University School of Medicine

Division name

Department of pediatrics

Zip code


Address

2-16-1, Sugao, Miyamae-ku, Kawasaki city, Kanagawa, Japan

TEL

044-977-8111

Homepage URL


Email

y2umezawa@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2018 Year 12 Month 07 Day

Date of IRB


Anticipated trial start date

2018 Year 12 Month 16 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2018 Year 12 Month 07 Day

Last modified on

2018 Year 12 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040084


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name